New drug BW-50218 put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study is testing a new drug, BW-50218, in 60 healthy adults to see if it is safe and how the body processes it. Participants receive a single injection of either the drug or a placebo. The main goal is to check for side effects and measure drug levels in the bloo…
Phase: PHASE1 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 05:09 UTC